Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes

被引:81
作者
Juntti-Berggren, L
Refai, E
Appelskog, I
Andersson, M
Imreh, G
Dekki, N
Uhles, S
Yu, L
Griffiths, WJ
Zaitsev, S
Leibiger, I
Yang, SN
Olivecrona, G
Jörnvall, H
Berggren, PO [1 ]
机构
[1] Karolinska Inst, Rolf Luft Ctr Diabet Res, Dept Mol Med, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med Biochem & Biophys, SE-17176 Stockholm, Sweden
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17176 Stockholm, Sweden
[4] Umea Univ, Dept Med Biosci & Physiol Chem, SE-90187 Umea, Sweden
关键词
D O I
10.1073/pnas.0403551101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In type 1 diabetes (T1D), there is a specific destruction of the insulin secreting pancreatic beta cell. Although the exact molecular mechanisms underlying beta cell destruction are not known, sera from T1D patients have been shown to promote Ca2+-induced apoptosis. We now demonstrate that apolipoprotein CIII (apoCIII) is increased in serum from T1D patients and that this serum factor both induces increased cytoplasmic free intracellular Ca2+ concentration ([Ca2+](i)) and beta cell death. The apoCIII-induced increase in [Ca2+](i) reflects an activation of the voltage-gated L-type Ca2+ channel. Both the effects of T1D sera and apoCIII on the beta cell are abolished in the presence of antibody against apoCIII. Increased serum levels of apoCIII can thus account for the increase in beta cell [Ca2+](i) and thereby beta cell apoptosis associated with T1D.
引用
收藏
页码:10090 / 10094
页数:5
相关论文
共 32 条
[1]  
ALMUHTASEB N, 1992, PEDIATRICS, V89, P936
[2]   SERUM-LIPOPROTEINS AND APOLIPOPROTEINS IN RATS WITH STREPTOZOTOCIN-INDUCED DIABETES [J].
BARON, H ;
ROHEIM, PS ;
EDER, HA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (03) :714-721
[3]  
BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345
[4]   PLASMA APOLIPOPROTEIN C-III LEVELS IN CHILDREN WITH TYPE-I DIABETES [J].
BLACKETT, P ;
SARALE, DC ;
FESMIRE, J ;
HARMON, J ;
WEECH, P ;
ALAUPOVIC, P .
SOUTHERN MEDICAL JOURNAL, 1988, 81 (04) :469-473
[5]   QUANTIFICATION OF HUMAN PLASMA APOLIPOPROTEINS C-I, C-II, AND C-III BY RADIOIMMUNOASSAYS [J].
BREN, ND ;
RASTOGI, A ;
KOTTKE, BA .
MAYO CLINIC PROCEEDINGS, 1993, 68 (07) :657-664
[6]  
BREWER HB, 1974, J BIOL CHEM, V249, P4975
[7]   ANALYSIS OF PLASMA-LIPIDS AND APOLIPOPROTEINS IN INSULIN-DEPENDENT AND NONINSULIN-DEPENDENT DIABETICS [J].
BRIONES, ER ;
MAO, SJT ;
PALUMBO, PJ ;
OFALLON, WM ;
CHENOWETH, W ;
KOTTKE, BA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (01) :42-49
[8]   ISOFORMS OF RAT APOLIPOPROTEINS AND CHANGES INDUCED BY INSULIN DEFICIENCY AND FASTING [J].
CALLOW, MJ ;
REDGRAVE, TG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1168 (03) :271-279
[9]  
CHEN M, 1994, J LIPID RES, V35, P1918
[10]  
EFENDIC S, 1991, J INTERN MED, V229, P9